What is the recommended dosage of amoxicillin (amoxicillin)-clavulanate (clavulanic acid) for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin-Clavulanate Dosing for Adults

For adults with mild to moderate infections, the standard dose is 500 mg/125 mg every 8 hours or 875 mg/125 mg every 12 hours, but for respiratory infections with risk factors for resistance or moderate-to-severe disease, use the high-dose regimen of 2000 mg/125 mg twice daily. 1, 2, 3

Standard Adult Dosing

  • Mild to moderate infections: 500 mg/125 mg every 8 hours OR 875 mg/125 mg every 12 hours 3
  • Respiratory tract infections without risk factors: 625 mg (500 mg/125 mg) three times daily 1, 4
  • The FDA-approved usual adult dose is one 500 mg/125 mg tablet every 12 hours or one 250 mg/125 mg tablet every 8 hours 3

High-Dose Regimen for Resistant Pathogens

Use 2000 mg/125 mg twice daily when any of the following risk factors are present: 1, 2

  • Antibiotic use within the past 4-6 weeks 1, 2
  • Age >65 years 2
  • Recent hospitalization 2
  • Immunocompromised status 2
  • Geographic regions with >10% penicillin-resistant Streptococcus pneumoniae 1, 2
  • Close contact with daycare facilities 2
  • Smoking or household smoker exposure 2
  • Moderate to severe symptoms (fever ≥39°C, systemic toxicity) 2
  • Frontal or sphenoidal sinusitis 2
  • Comorbid conditions (diabetes, chronic cardiac/hepatic/renal disease) 2

The 2000 mg/125 mg formulation uses a pharmacokinetically enhanced, modified-release mechanism that maintains therapeutic amoxicillin levels for approximately 49% of the 12-hour dosing interval at an MIC of 4 mcg/mL—a level unachievable with conventional formulations. 5 This extended coverage is critical for eradicating penicillin-resistant S. pneumoniae with MICs up to 4-8 mg/L. 6, 7

Treatment Duration by Indication

  • Acute bacterial rhinosinusitis: 5-7 days 1, 2
  • Community-acquired pneumonia: 7-10 days 4
  • Acute exacerbations of chronic bronchitis: 5 days with high-dose formulation is as effective as 7 days with standard dosing 8
  • Uncomplicated urinary tract infections: 3-7 days 4

Administration Guidelines

  • Take at the start of a meal to enhance clavulanate absorption and minimize gastrointestinal intolerance 3
  • Evaluate clinical response within 48-72 hours; if no improvement, consider changing antibiotics or reevaluating the diagnosis 1, 4

Critical Dosing Pitfalls to Avoid

Do NOT substitute two 250 mg/125 mg tablets for one 500 mg/125 mg tablet—they contain the same amount of clavulanate (125 mg each), making them non-equivalent. 3 This is a common prescribing error that results in clavulanate overdosing.

Avoid underdosing in high-resistance areas: In regions where penicillin-resistant S. pneumoniae prevalence exceeds 10%, always use the high-dose formulation (2000 mg/125 mg twice daily) to achieve adequate serum concentrations. 1, 2

Do NOT use macrolides or trimethoprim-sulfamethoxazole as alternatives due to resistance rates exceeding 40% for macrolides and 50% for TMP-SMX against S. pneumoniae. 2

Alternative Therapies for Penicillin Allergy

  • Type I hypersensitivity: Use doxycycline or respiratory fluoroquinolones (levofloxacin or moxifloxacin) 1, 2
  • Non-Type I hypersensitivity: Consider clindamycin plus a third-generation oral cephalosporin 2

The high-dose formulation has demonstrated equivalent or superior clinical efficacy (91.5-93% success rates) compared to standard dosing in community-acquired pneumonia, with no difference in adverse event rates. 7, 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.